Profound Medical Corp.
PROF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001628808
No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Profound Medical Corp. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 35 | 34 | −1 |
| Shares | 8.78M | 8.47M | −307.3K (−3.5%) |
| Value | $35.6M | $91.7M | +$56.2M (+158.0%) |
New holders (3)
Institutions that held Profound Medical Corp. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 29,832 | $324.9K | 0.00% |
| Sutton Wealth Advisors Inc. | 5,000 | $54.5K | 0.02% |
| Belpointe Asset Management LLC | 186 | $2.03K | 0.00% |
Sold out (4)
Institutions that held Profound Medical Corp. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 732,543 | $2.96M |
| Gilder Gagnon Howe & Co LLC | 145,613 | $588.0K |
| Caption Management, LLC | 61,225 | $247.0K |
| Tower Research Capital LLC (TRC) | 3,100 | $13.0K |